Dysport exerts its therapeutic results by inhibiting acetylcholine release for the neuromuscular junction. It selectively targets and binds to presynaptic nerve terminals, stopping the discharge of neurotransmitters answerable for muscle mass contraction.Therapy with DYSPORT and various botulinum toxin solutions may lead to swallowing or breathing